Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tomoki MORIKAWA"'
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283844 (2023)
Blood vessel rupture is a major complication associated with vascular access intervention therapy (VAIVT). However, information regarding the risk factors for ruptures related to VAIVT is limited. The purpose of this study was to investigate the risk
Externí odkaz:
https://doaj.org/article/32ed300a1a1641e18b69828be7bfc262
Publikováno v:
JAPANESE JOURNAL OF MULTIPHASE FLOW. 36:55-62
Autor:
Masahide Mizobuchi, Masahiko Murakami, Tomoki Morikawa, Motonori Sugiyama, Osamu Yoshitake, Nozomi Miyazawa, Toma Hamada, Hirokazu Honda, Takeshi Aoki, Kei Matsumoto, Tomohiro Saito
Publikováno v:
Clinical Nephrology. 95:166-170
We report a case of a 32-year-old man who was undergoing chronic hemodialysis and had hyperphosphatemia and secondary hyperparathyroidism (SHPT) with multiple tumoral calcinosis (TC) lesions refractory to drug therapy. Total parathyroidectomy and aut
Autor:
Masahide Mizobuchi, Junichi Hayashi, Nobuhiro Kanazawa, Yuuki Mima, Ayana Iida, Motonori Sugiyama, Kei Fukuda, Hirokazu Honda, Tomoki Morikawa, Taihei Suzuki, Yasuto Shikida, Tomohiro Saito, Yusuke Miwa
Publikováno v:
Journal of Clinical Apheresis. 36:196-205
We present six cases of antimelanoma differentiation-associated gene 5 antibody (anti-MDA5-Ab)-positive clinically amyopathic dermatomyositis (CADM) with rapidly progressive interstitial lung disease (RP-ILD), which is known to have a poor prognosis.
Autor:
Tomoki Morikawa, Masashi Sakaki, Taihei Suzuki, Hitoshi Yoshida, Akira Yamamiya, Takanori Shibata, Masayuki Iyoda, Taro Inaba, Kei Matsumoto, Nobuhiro Kanazawa
Publikováno v:
Nihon Toseki Igakkai Zasshi. 52:185-190
Autor:
Masayuki Iyoda, Takako Inokuchi, Tsutomu Hirano, Yasuto Shikida, Ken Iseri, Tomoki Morikawa, Takanori Shibata, Noriko Hara
Publikováno v:
Diabetic Medicine. 34:1788-1791
Background Type B insulin resistance syndrome is a rare disease characterized by refractory transient hyperglycaemia and severe insulin resistance associated with circulating anti-insulin receptor antibodies. A standardized treatment regimen for type
Publikováno v:
The Proceedings of Mechanical Engineering Congress, Japan. 2019:J02601
Publikováno v:
The Proceedings of the Fluids engineering conference. 2016:GS18